DUBLIN--(BUSINESS WIRE)--The "Personalized Medicines - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Personalized Medicines estimated at US$227.9 Billion in the year 2020, is projected to reach a revised size of US$515.3 Billion by 2027, growing at a CAGR of 12.4% over the period 2020-2027.

Tests & Lab Services, one of the segments analyzed in the report, is projected to record 11.3% CAGR and reach US$296.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Targeted Therapeutics segment is readjusted to a revised 13.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $67.2 Billion, While China is Forecast to Grow at 12% CAGR

The Personalized Medicines market in the U.S. is estimated at US$67.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$90.5 Billion by the year 2027 trailing a CAGR of 12% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 10.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Select Competitors (Total 87 Featured):

• Abbott Molecular
• Beckman Coulter, Inc.
• bioMerieux SA
• Bristol-Myers Squibb Company
• Dako Denmark A/S
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Hologic, Inc.
• Lab 21 Limited
• Macrogen, Inc.
• NeoGenomics Laboratories, Inc.
• Novartis AG
• QIAGEN NV
• Rosetta Genomics Ltd.
• Thermo Fischer Scientific Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Access to Valuable Genetic Information Ushers Transformation in Medicine
• Recent Market Activity
• Market Outlook
• Adoption of Personalized Medicines - A Peek into Developed and Developing Economies
• Increasing Market Availability of Personalized Medicines
• Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area
• Constraints in Traditional Approach to Treatment Creates Need and Demand for Personalized Medicine
• Economics of Personalized Medicine
• Is Emergence of Personalized Medicine Signaling the End of Blockbusters?
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Growth Drivers in a Gist
• Key Market Restraints
• Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
• Oncology - A Major Application Market
• Diagnosed Cases of Cancer on the Rise
• World Cancer Statistics: Incidence and Mortality Data
• Growing Cancer Cases in Developing Countries Bodes Well for the Personalized Medicine Market
• Growing Importance of Personalized Drugs for Cancer Treatment
• Ballooning Global Population Offers Significant Growth Opportunities
• Aging Global Population Drives Personalized Medicines
• Increasing Healthcare Spending in Emerging Markets
• Changing Patients' Trends Drive Personalized Medicine
• Technological Advancements and Consumer Push to Drive Personalized Medicine
• Minimizing Adverse Events - A Major Benefit of Personalized Medicines
• Personalized Medicines Brings Disease Prevention Closer to Reality
• Ability to Manage Healthcare Costs Piques Industry and Government Alike
• Potential to Uncover Additional Prospective Targets - A Major Benefit in Pursuit
• Elimination of Invasive Tests Attracts Patients and Doctors towards Molecular Test-based Personalized Medicines
• Genomics to Dictate Advancement of Personalized Medicines
• Companion Diagnostics Drive Personalized Medicine
• Biomarkers as Companion Diagnostics
• Personalized Medicines Help Reducing R&D Costs
• Personalized Medicine - A Corporate Growth Strategy
• Development Pipeline Reveals Promising Picture for Personalized Medicine
• Advancements in Biomedical Imaging to Enhance Personalized Medicines
• Increasing Use of Personalized Medicines Drives Genetic Testing
• Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market
• Next-Generation Sequencing - A Giant Leap in Genome Sequencing
• Single Nucleotide Polymorphism (SNP) - Making Advancements in Personalized Medicine
• Personalized Medicine Goes Beyond DNA Analysis
• Combination Approaches May Mark Future Endeavors

4. GLOBAL MARKET PERSPECTIVE

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/c5h444

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900